1
828 Original Papers
1
4 Romano S, DʼAngelillo A, Pacelli R, Staibano S, De Luna E, Bisogni R, Eske-
linen EL, Mascolo M, Calì G, Arra C, Romano MF. Role of FK506-binding
protein 51 in the control of apoptosis of irradiated melanoma cells. Cell
Death Differ 2010; 17: 145–157
which are considered checkpoints of S, G1, and G1/S phases tran-
sition, respectively. Further studies are in progress to evaluate the
Kip1
INK4a
role of p27
rest.
and p16
in the labdane-induced cell cycle ar-
15 Fang JM, Chen YC, Wang BW, Cheng YS. Terpenes from hearthwood of
Juniperus chinensis. Phytochemistry 1996; 41: 1361–1365
1
6 Su WC, Fang JM, Cheng YS. Labdanes from Cryptomeria japonica. Phyto-
chemistry 1994; 37: 1109–1114
Acknowledgements
!
1
7 Garbarino JA, Oyarzun M, Gambaro V. Labdane diterpenes from Arau-
cari araucana. J Nat Prod 1987; 50: 935–936
MS and NMR spectra were provided by CSIAS, Università di Na-
poli Federico II, Italy. We are grateful for the financial assistance
provided by the Osservatorio Ambientale Permanente della Bio-
diversità (Convenzione – Colli al Volturno).
18 Su WC, Fang JM, Cheng YS. Diterpenoids from leaves of Cryptomeria ja-
ponica. Phytochemistry 1996; 41: 255–261
1
9 San Feliciano A, Medarde M, Lopez JL, Del Corral M, Puebla P, Barrero AF.
Terpenoids from leaves of Juniperus thurifera. Phytochemistry 1988;
2
7: 2241–2248
2
0 Hasegawa S, Hirose Y. A diterpene glycoside and lignans from seed of
Thujopsis dolabrata. Phytochemistry 1980; 19: 2479–2481
1 Sakar MK, Er N, Ercil D, Del Olmo E, San Feliciano A. (−)-Desoxypodo-
phyllotoxin and diterpenoids from Juniperus nana Willd. berries. Acta
Pharm Turcica 2002; 44: 213–219
2
Conflict of Interest
!
All authors declare no conflict of interest.
2
2 Fang JM, Sou YC, Chiu YH, Cheng YS. Diterpenes from the bark of Junipe-
rus chinensis. Phytochemistry 1993; 34: 1581–1584
References
23 De Pascual TJ, Barrero AF, Muriel L, San Feliciano A, Grande M. New nat-
ural diterpene acids from Juniperus communis. Phytochemistry 1980;
19: 1153–1156
24 Herz W, Watanabe K. Sesquiterpene alcohols and triterpenoids from
Liatris microcephala. Phytochemistry 1983; 22: 1457–1459
25 Estevez-Braun A, Estevez-Reyes R, Gonzalez AG. 13C NMR assignments of
some dibenzyl-γ-butyrolactone lignans. Phytochemistry 1996; 43:
885–886
1
Kwon HJ, Hong YK, Park C, Choi YH, Yun HJ, Lee EW, Kim BW. Widdrol
induces cell cycle arrest, associated with MCM down-regulation, in hu-
man colon adenocarcinoma cells. Cancer Lett 2010; 290: 96–103
Angioni A, Barra A, Russo MT, Coroneo V, Dessi S, Cabras P. Chemical
composition of the essential oils of Juniperus from ripe and unripe ber-
ries and leaves and their antimicrobial activity. J Agric Food Chem
2
2
003; 51: 3073–3078
3
4
Filipowicz N, Kaminski M, Kurlenda J, Asztemborska M, Ochocka JR. Anti-
bacterial and antifungal activity of juniper berry oil and its selected
components. Phytother Res 2003; 17: 227–231
Nakanishi T, Iida N, Inatomi Y, Murata H, Inada A, Murata J, Lang FA, Ii-
numa M, Tanaka T, Sakagami Y. A monoterpene glucoside and three
megastigmane glycosides from Juniperus communis var. depressa.
Chem Pharm Bull 2005; 53: 783–787
Martin AM, Queiroz EF, Marston A, Hostettmann K. Labdane diterpenes
from Juniperus communis L. berries. Phytochem Anal 2006; 17: 32–35
Innocenti M, Michelozzi M, Giaccherini C, Ieri F, Vincieri FF, Mulinacci N.
Flavonoids and biflavonoids in Tuscan berries of Juniperus communis
L.: detection and quantitation by HPLC/DAD/ESI/MS. J Agric Food Chem
26 Kizu H, Shimana H, Tomimori T. Studies on the constituents of Clematis
species. The constituents of Clematis stans SIEB. et ZUCC. Chem Pharm
Bull 1995; 43: 2187–2194
27 Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich
S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC. p53 mutations,
ras mutations, and p53-heat shock 70 protein complexes in human
lung carcinoma cell lines. Cancer Res 1991; 51: 4090–4096
28 Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras
provokes premature cell senescence associated with accumulation of
p53 and p16INK4a. Cell 1997; 88: 593–602
29 Groth A, Weber JD, Willumsen BM, Sherr CJ, Roussel MF. Oncogenic Ras
induces p19ARF and growth arrest in mouse embryo fibroblasts lack-
ing p21Cip1 and p27Kip1 without activating cyclin D-dependent ki-
nases. J Biol Chem 2000; 275: 27473–27480
30 Roper E, Weinberg W, Watt FM, Land H. p19ARF-independent induc-
tion of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO
Rep 2001; 2: 145–150
5
6
2
007; 55: 6596–6602
7
8
Demetzos C, Dimas K. Labdane-type diterpenes: chemistry and biolog-
ical activity. In: Atta-Ur-Rahman, editor. Studies in natural products
chemistry of bioactive natural products, Vol. 25. Oxford: Elsevier Sci-
ence; 2001: 235–292
Dimas K, Papadaki M, Tsimplouli C, Hatziantoniou S, Alevizopoulos K,
Pantazis P, Demetzos C. Labd-14-ene-8,13-diol (sclareol) induces cell
cycle arrest and apoptosis in human breast cancer cells and enhances
the activity of anticancer drugs. Biomed Pharmacother 2006; 60:
31 Olsen CL, Gardie B, Yaswen P, Stampfer MR. Raf-1-induced growth arrest
in human mammary epithelial cells is p16-independent and is over-
come in immortal cells during conversion. Oncogene 2002; 21: 6328–
6339
1
27–133
32 Esposito F, Cuccovillo F, Vanoni M, Cimino F, Anderson CW, Appella E,
Russo T. Redox-mediated regulation of p21(waf1/cip1) expression in-
volves a post-transcriptional mechanism and activation of the mito-
gen-activated protein kinase pathway. Eur J Biochem 1997; 245: 730–
737
9
Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of
G1-phase progression. Genes Dev 1999; 13: 1501–1512
0 Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators
and beyond. Dev Cell 2008; 14: 159–169
1
1
1 Kupchan SM, Britton RW, Ziegler MF, Sigel CW. Bruceantin, a new potent
antileukemic simaroubolide from Brucea antidysenterica. J Org Chem
33 Park JW, Jang MA, Lee YH, Passaniti A, Kwon TK. p53-independent ele-
vation of p21 expression by PMA results from PKC-mediated mRNA
stabilization. Biochem Biophys Res Commun 2001; 280: 244–280
34 Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK. TIS21/BTG2/PC3 is
expressed through PKC-delta pathway and inhibits binding of cyclin
B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res
2004; 299: 159–170
35 Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman
CC. Structural organization of the neutrophil NADPH oxidase: phos-
phorylation and translocation during priming and activation. J Leukoc
Biol 2005; 78: 1025–1042
1
973; 38: 178–179
1
1
2 Hara S, Okabe H, Mihashi K. Gas-liquid chromatographic separation of
aldose enantiomers as trimethylsilyl ethers of methyl 2-(polyhy-
droxyalkyl)-thiazolidine-4-(R) carboxylates. Chem Pharm Bull 1987;
3
5: 501–506
3 Iaccio A, Collinet C, Montesano Gesualdi N, Ammendola R. Protein kinase
C-alpha and ‑delta are required for NADPH oxidase activation in
WKYMVm-stimulated IMR90 human fibroblasts. Arch Biochem Bio-
phys 2007; 459: 288–294
De Marino S et al. Imbricatolic Acid from… Planta Med 2011; 77: 1822–1828